Skip navigation

In this issue...

Innovation – the centre of corporate strategiese
Lord Sainsbury, UK Minister for Science and Innovation
British Innovations
On the road again
Christopher Macgowan, Chief Executive, Society of Motor Manufacturers and Traders
Fossil Fuels – An Energy source for the Future
Greg Lewin, President, Shell Global Solutions
Chain of success
Kenny McKay, Director, and Will Wright, Manager, Restructuring practice at KPMG
Innovation and the Patent Office
Lawrence Smith-Higgins, Head of Awareness Information & Media The UK Patent Office
Benefits of association
Dr Michael Moore, CEO, PIramed Ltd
Innovation and strength in the UK biotech sector
Aisling Burnand, Chief Executive, BioIndustry Association
Simfonec: Helping make good research BIG business
Heron Evidence Development: Successful deal of missed opportunity
Springwell Ltd: Match-maker for Innovative Technologies
Korn/Ferry International: Pharmaceutical companies desire to break the mould
A quality core interface
Dominique Kleyn head of BioPharma Business Development, Imperial College London
Evolutec Group: Creating a range of commercial options
Moving forward
Dr Ceri Williams, Senior Manager, Science and Innovation at Yorkshire Forward and Dr Danielle Hankin, Bioscience Cluster Manager
Oxitech: Revolutionising SIT Programmes
Oxford Expression Technologies: Meeting the needs of the post-genomic era
Business Services
Innovating business related services
Norma Rose, Director-General, Business Services Association
BT: Innovation Strategy and Innovation Continuum
UK Film Council: How the UK wins in the international film industry?
On the defence
Major General Alan Sharman CBE, Director General, Defence Manufacturers Association
ProEtch: Precision parts of quality
Wallop Defence Systems: Aircraft Countermeasures and the Dual Spectral Threat
Education, Education, Education
Ruth Kelly, Secretary of State for Education and Skills
Applied Sciences at Wolverhampton - Innovation in Higher Education Professor Trevor Hocking, Associate Dean, International Development
Wind energy
Marus Rand, Chief Executive, British Wind Energy Association
Vital energy
Ian Leitch, Commercial Director, Energy Industries Council
Waterman Group: Solutions to solve climate control legislation
Winning the war against germs
Dr Ron Mitchell, Managing Director, GB Environmental
Show me the money! Funding for innovation – who can help?
UK: Innovation Nation?
Launching the “Innovation Nation?” initiative
Innovation in the 21st Century
Gemma Harman, Director of Strategy & Media, BT Chief Technology Office
UK Manufacturing - a driving force for innovation
Andrew Manly, Director General, Manufacturing Technologies Association
Waterman Group: Single project model 3D
Renishaw: Achieving global manufacturing competitiveness in the UK
Yorkshire Forward
The European Nanotechnology Trade Alliance
Del Stark, Chief Executive, European Nanotechnology Trade Alliance
University research drives a new wave of innovation
Omar Cheema, Nanotechnology Business Development, Imperial College London
Oxford Instruments: Enabling nanoscience and nanotechnology
Semefab (Scotland): A real driver of change
Metal Nanopowders: New products that meet your needs
Regional Development
London Development Agency: One jump ahead
91Advantage West Midlands: At the heart of it all 95


The European Nanotechnology Trade Alliance


Del Stark, Chief Executive European Nanotechnology Trade Alliance

The UK had an early interest in nanotechnology, with a Department of Trade & Industry (DTI) National Nanotechnology Initiative (NION) announced in 1986, followed in 1988 by a four-year LINK Nanotechnology programme. After this time there was no national strategy for nanotechnology in the UK, although dispersed research involving nanoscale science continued to be funded. In 1997, the Institute of Nanotechnology (IoN), a registered charity, was created to fill the gap and act as a focus of interest in nanotechnology throughout the UK. The Institute grew out of the Centre for Nanotechnology, which had received a small amount of funding under NION to raise awareness of nanotechnology and its applications.

The Institute of Nanotechnology is a recognised global leader in its field and has recently established the European Nanotechnology Trade Alliance as a trade body designed to represent industry. Experts from the UK Advisory Group for Nanotechnology applications suggest the UK should focus on six application areas where they reckoned the UK has research strength and industrial opportunities.

These are: electronics and communications; drug delivery systems; tissue engineering, medical implants and devices; nanomaterials, particularly at the bio/medical/functional interface; instrumentation, tooling and metrology; and sensors and actuators.

The UK has now become a European leader in nanotechnology investment. In 2002, the Department of Trade and Industry dedicated approximately £30m to nanoscale research, on top of existing funding for subject-specific research councils. This figure however will be dwarfed by the new UK Initiative, which will seek to place nanoscale research firmly in the mainstream of future technology development.

The UK has now become a European leader in nanotechnology investment

On 2 July 2003, Lord Sainsbury, Science and Innovation Minister, announced a cash injection of £90m over the next six years to help industry harness the commercial opportunities offered by nanotechnology. Existing and anticipated micro and nanotechnology projects supported by the UK development agencies are expected to exceed £200m over the next few years. From an industrial point of view the UK is leading in many fields including bionanotechnology, nanomedicine, materials science and metrology.

The UK has about 171 companies involved in nanotechnology research and commercialisation. Thomas Swan for instance has recently launched its new Carbon Nanomaterials business that is dedicated to manufacturing commercial quantities of high-purity single and multi-wall carbon nanotubes under the Elicarb trademark. PSiMedica Limited, located in Malvern, was founded in 2000 to exploit the potential of BioSiliconTM, a new, proprietary biomaterial based on nanostructured porous silicon.

PSiMedica is focusing initially on the development of BioSiliconTM for the controlled release of therapeutic agents. NPL is the United Kingdom?s national standards laboratory, an internationally respected and independent centre of excellence in research, development and knowledge transfer in measurement and materials science. NPL has recently launched a metrology club to work with industry in developing new standards.

Nanotechnology has the potential to benefit society, individuals and industry alike. In light of the increasingly serious problems relating to the degeneration of the environment, threat to the biosphere, increasing demands for resources by developing countries, and the growing abyss between rich and poor, the European Nanotechnology Trade Alliance (ENTA) is particularly interested in promoting those nanotechnologies that offer sustainable energy generation, less resource-intensive manufacturing and cheaper and better medicines.

Supported by companies such as Procter and Gamble, BP International, Thomas Swan & Co., Nexia Solutions, Imerys, SmartBead Technologies and LOT-Oriel, the European Nanotechnology Trade Alliance, (ENTA), has been created to represent the interests of nanotechnology businesses across Europe. It will act to bridge the gap between industry, governments, science, and importantly, the public. Its aim is to promote the benefits of nanotechnology, while supporting all actions that ensure new nanotechnologies are developed in a safe and responsible manner.

Membership of ENTA is open to businesses and organisations for whom nanotechnology has or may have an impact, and includes patent agents and service organisations such as the Institute of Occupational Medicine, Mewburn Ellis LLP, Marks and Clerk and Darbys.

Membership of ENTA offers:

ENTA will work closely with the media and government bodies to express industry?s views and needs, on for example, legislation, standards, standard operating procedures, and build strong relationships with NGOs and the public so to ensure full community engagement.

ENTA fully endorses and supports the world movements aimed at delivering the eight Millennium Development Goals, such as eradicating poverty and disease to ultimately improving the life expectancy and quality of life for everyone in the developing world. Nanotechnology has a role to play in this from the production of clean drinking water to sustainability of new manufacturing processes.

ENTA held its first strategy meeting in London on 23 July to collect views and opinions relating to the nanotechnology community and its growing industry. Del Stark, Chief Executive of ENTA, said ?Industry will shape the future of ENTA in both advisory and member capacities.

Our meeting today teased out many issues of interest and concern, as wide as the need for public communication, in depth understanding of where potential risks may occur, a lack of precise definitions and the overall perception barrier relating to nanotechnology.? He added ?ENTA aims to address these issues, and become the first port of call for the media, as representing the industry view on nanotechnology.?

ENTA exhibited at the flagship European conference ?Nanotechnology and the Health of the EU Citizen in 2020? in Edinburgh during the week beginning the 5th of September. ENTA participated in the press conference at this event and received much interest from the media and the conference delegates.

ENTA?s next steps will be to carry out market research and market surveys in order to gain and evaluate market perception. ENTA is already beginning to establish relationships with many relevant bodies across Europe, such as the UK MNT network, the European Commission and many multinational companies. It intends to issue regular media briefings, and press releases on items of international industrial and public importance.

ENTA?s flagship event will be in the Autumn, where it is sponsoring the conference at Europe?s biggest nanotrade fair, ?NanoSolutions?, to be held in Cologne on 8-10 November.

Contact: Del Stark, Chief Executive
European Nanotechnology Trade Alliance
Tel: +44 (0) 141 330 2143
Fax: +44 (0) 141 330 2144